CRO
CRO company profile
Latest price
As of — · Market data by Massive
Market cap
—
Volume
—
Previous close
—
Day range
—
Listed
—
Coverage
5 articles
Price performance
Recent trading
Newsroom
Latest CRO coverage
Latest Analysis Reveals 65% of US Biotechs Struggle to Identify Suitable CRO Partner
[ad_1] SAN FRANCISCO – (NewMediaWire) – January 12, 2024 – (ACN Newswire) – Avance Clinical, the leading Australian and North American CRO for biotechs, announced today that a new industry analysis shows 60-65% of US biotechs face challenges identifying the right sized CRO partner that can deliver at every phase of their drug developm
Sino Biological Announces the Opening of Its New US-Based Center for Bioprocessing
[ad_1] HOUSTON, TX – (NewMediaWire) – October 9, 2023 – Sino Biological, Inc. (“Sino Biological” or the “Company”), a biotechnology company listed on the Shenzhen stock exchange subsidiary ChiNext (SZSE: 301047), which provides biological research reagents and related technical contract research services, is pleased to announce the formal
Asia Pacific Cell & Gene Research Growing 50% Faster Than ROW
[ad_1] SYDNEY – (NewMediaWire) – February 3, 2023 – (ACN Newswire) – Novotech, the leading Asia Pacific focused biotech specialist CRO and recipient of the Asia Pacific Cell & Gene Therapy Clinical Trials Excellence award, said the number of cell & gene therapy trials in the region was growing 50% faster than ROW. The majority of tria
Sino Biological and Ainnocence Partner to Offer Next-Generation CRO Antibody Development Services
[ad_1] Beijing, China – (NewMediaWire) – March 28, 2022 – Sino Biological, Inc.(“Sino Biological” or the “Company”), a biotechnology company listed on the Shenzhen stock exchange subsidiary ChiNext (SZSE: 301047), which provides biological research reagentsand related technical contract research services, is pleased to announce a CRO servic
Sino Biological Establishes New Location in Houston, Texas
[ad_1] Houston, TX – (NewMediaWire) – January 6, 2022 – Sino Biological, Inc. (“Sino Biological” or the “Company”), a biotechnology company listed on the Shenzhen stock exchange subsidiary ChiNext (SZSE:301047) that provides biological research reagents and related technical contract research services, is pleased to announce its physical ge